EUVIMEDEUVIMED entdecken
Crossref

Survival by Heart Failure Phenotype in a Fontan Surveillance Population, 2010–2023

Lindsey C Ivey, Cheryl L Raskind-Hood, Fred H Rodriguez, Giancarlo Licitra, Ryan O Sheets, Mollie R Westrick, Yuting Guo, Abeed Sarker, Wendy M Book

Pediatric Cardiology · 2026

DOI: 10.1007/s00246-025-04145-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Cardiology, 2026. Verfasst von Lindsey C Ivey und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Emory University Rollins School of Public Health, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA. lcivey@emory.edu. Hauptthemen laut MEDLINE: Fontan Procedure, Heart Failure, Heart Defects, Congenital. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: CDC HHS, JG CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The Fontan operation palliates single-ventricle defects but is associated with late morbidity, heart failure (HF), and premature mortality. Long-term survival among Fontan patients by HF phenotype and transplant status are evaluated. METHODS: We identified 722 Fontan patients (median age 10.2 years at first encounter; 57.3% male; 41.1% Black) with healthcare encounters between 2010 and 2023. The cohort was linked to death certificates. HF was categorized by ICD codes as systolic (SHF) or non-systolic (NSHF). Transplant evaluation and procedures were validated by chart review. The first HF-coded encounter, transplant evaluation and transplant date were recorded. Survival was analyzed using Kaplan-Meier methods. RESULTS: Patients without HF were younger [median 6.3 years (5.0-56.0)] than those with NSHF [21.1 years (5.0-44.7)], SHF [16.1 years (5.0-53.0)], transplant [17.3 years (5.3-47.3)], or evaluation without transplant [18.0 years (5.4-50.2)]. Fifty-seven patients died (7.9%, median age 24.6 years). Mortality occurred in 2.8% (no HF), 6.4% (NSHF), 14.0% (SHF), 28.6% (evaluated, not transplanted), and 30.6% (transplanted; p < 0.001). Post-transplant 1-, 5-, and 10-year survival was 91.7%, 74.4%, and 61.8%, compared to 96.2%, 91.9%, and 77.2% for SHF. NSHF and no HF groups had similar 5-year survival (97.3%). Among 28 patients evaluated but not transplanted, 1-year mortality was 26.6%. CONCLUSION: The SHF Fontan phenotype was associated with significantly worse survival than Fontan patients without SHF, who have favorable long-term outcomes. Although transplant offers potential benefit, long-term post-transplant survival remains limited. Improved risk stratification to guide optimal transplant timing is essential for this high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fontan ProcedureHeart FailureHeart Defects, CongenitalHumansMaleFemalePhenotypeAdolescentChildHeart TransplantationChild, PreschoolAdultYoung AdultMiddle AgedSurvival Rate

Stichwörter der Autor:innen

Congenital heart diseaseFontanHeart failureHeart transplantSingle ventricleSurvival

Autor:innen und Institutionen

  • Department of Epidemiology, Emory University Rollins School of Public Health, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA. lcivey@emory.edu.
  • Department of Epidemiology, Emory University Rollins School of Public Health, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA.
  • Division of Cardiology, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA, 30322, USA.
  • School of Medicine, Emory University, 100 Woodruff Circle, Atlanta, GA, 30322, USA.
  • Department of Biomedical Informatics, School of Medicine, Emory University, 100 Woodruff Circle, Atlanta, GA, 30322, USA.

Förderung

  • CDC HHS
  • JG CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Ivey, L. C., Raskind-Hood, C. L., Rodriguez, F. H., Licitra, G., Sheets, R. O., Westrick, M. R., Guo, Y., Sarker, A., & Book, W. M. (2026). Survival by Heart Failure Phenotype in a Fontan Surveillance Population, 2010–2023. Pediatric Cardiology. https://doi.org/10.1007/s00246-025-04145-4

Vancouver

Ivey LC, Raskind-Hood CL, Rodriguez FH, Licitra G, Sheets RO, Westrick MR, et al. Survival by Heart Failure Phenotype in a Fontan Surveillance Population, 2010–2023. Pediatric Cardiology. 2026. doi:10.1007/s00246-025-04145-4

BibTeX
@article{Ivey2026,
  author = {Ivey, Lindsey C and Raskind-Hood, Cheryl L and Rodriguez, Fred H and Licitra, Giancarlo and Sheets, Ryan O and Westrick, Mollie R and Guo, Yuting and Sarker, Abeed and Book, Wendy M},
  title = {Survival by Heart Failure Phenotype in a Fontan Surveillance Population, 2010–2023},
  journal = {Pediatric Cardiology},
  year = {2026},
  doi = {10.1007/s00246-025-04145-4}
}
Kostenlos starten →